Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy
- 1 October 2007
- journal article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 66 (10), 1284-1288
- https://doi.org/10.1136/ard.2006.066605
Abstract
To study the effects of short-term intermediate dose glucocorticoid (GC) therapy in patients with active rheumatoid arthritis (RA) on circulating endothelial progenitor cells (EPC), which are known to influence cardiovascular risk, and to elucidate mechanisms potentially responsible for the reduction of EPCs in patients with active RA. EPCs were quantified in 29 patients with active RA by flow cytometry, colony forming unit (CFU) and circulating angiogenic cell (CAC) assays before and after 7 days of intermediate dose GC therapy. CFU from patients with RA and from healthy referents (HR) were cultured in vitro in the absence or presence of dexamethasone (Dex) and/or TNF. After 1 week of GC therapy, EPC increased from 0.026 (SD 0.003)% to 0.053 (SD 0.010)% (p<0.01), and from 12 (SD 4) to 27 (SD 7) CFU/well (p<0.02); CAC also increased from 7 (SD 2) to 29 (SD 8) cells/high power field (p<0.05). In parallel, disease activity decreased significantly after GC treatment. TNF serum levels also decreased from 36 (SD 10) to 14 (SD 6) pg/ml (p<0.0001). Addition of Dex to the RA CFU led to a significant increase of mean CFU counts, whereas addition of TNF induced a decrease of CFU. Our data indicate that TNF may be at least partly responsible for the reduction of EPC seen in patients with RA. Intermediate doses of GCs for a short period of time, apart from reducing disease activity, significantly increase circulating EPC.Keywords
This publication has 36 references indexed in Scilit:
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular EventsNew England Journal of Medicine, 2002
- Anti–Tumor Necrosis Factor-α Treatment Improves Endothelial Function in Patients With Rheumatoid ArthritisCirculation, 2002
- Methotrexate and mortality in patients with rheumatoid arthritis: a prospective studyThe Lancet, 2002
- Low-Dose Prednisone Therapy for Patients with Early Active Rheumatoid Arthritis: Clinical Efficacy, Disease-Modifying Properties, and Side Effects: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialAnnals of Internal Medicine, 2002
- Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery DiseaseCirculation Research, 2001
- Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery DiseaseCirculation, 2001
- Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: Regulation of expression and activation by interleukin-1 and tumor necrosis factor ?Arthritis & Rheumatism, 2001
- Short term effects of corticosteroid pulse treatment on disease activity and the wellbeing of patients with active rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2001
- The Role of TNFα and IL-1 in Rheumatoid ArthritisPublished by S. Karger AG ,2000
- Is atherosclerosis a complication of long-term corticosteroid treatment?American Journal Of Medicine, 1986